Hikma Pharmaceutical reported 256M in EBIT for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Artemis Alpha ATS:LN -2669600000 1.65B
AstraZeneca AZN:LN 181.11B 36.36B
Bayer BAYN:GR 2.28B 1.89B
Fresenius FRE:GR 698M 105M
Galapagos GLPG:NA -76332000 55.19M
Genmab GEN:DC 1.25B 733M
GlaxoSmithKline GSK:LN 181.6B 5.9B
Hikma Pharmaceutical HIK:LN 256M 23M
Lonza Group LONN:SW 667M 116M
Merck MRK:GR 1.35B 146M
Orion ORNBV:FH 82M 10.5M
Recordati REC:IM 122.46M 15.94M